Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07620262 · ClinicalTrials.gov registry record · NA
Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study
A NA study, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07620262 is a NA study that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 50 participants.
The verdict
NCT07620262, a NA study, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a single-arm, open label, clinical outcome study to research the durability (success) of receiving a pulsed field ablation (PFA) per standard of care for treatment of atrial fibrillation during a subsequent procedure for the insertion of a left atrial appendage occlusion (LAAO) device. The reassessment of the initial ablation will be performed with or without additional ablation if needed.
Interventions
- DEVICE Remapping Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07620262
The ClinicalTrials.gov registry entry for NCT07620262 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remapping Procedure is the first listed.
NCT07620262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07620262 about?
NCT07620262 is a clinical study titled "Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study". This is a single-arm, open label, clinical outcome study to research the durability (success) of receiving a pulsed field ablation (PFA) per standard of care for treatment of atrial fibrillation during a subsequent procedure for the insertion of a left atrial appendage occlusion (LAAO) device. The r...
What is the current status of trial NCT07620262?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-05-01. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07620262?
The interventions under investigation include: Remapping Procedure (DEVICE).
Who is sponsoring clinical trial NCT07620262?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.